[Corrigendum] FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo

Following the publication of the above article, an interested reader drew to the authors’ attention that, regarding the cell migration and invasion assay experiments shown in Fig. 3 on p. 6, a number of data panels showed overlapping sections (specifically, two pairs of panels in Fig. 3C and two further pairs in Fig. 3D), such that data which were intended to show the results of differently performed experiments had apparently been derived from the same original sources. Upon performing an independent analysis of the data in this paper in the Editorial Office, it came to light that a third pair of data panels in Fig. 3D were similarly affected. Furthermore, upon asking the authors for an explanation of the apparent anomalies in these figures, they identified an additional unintended image duplication in Fig 3. These errors inadvertently arose during the process of final assembly and integration of multiple image panels in this figure. The authors were able to consult their original data, and realized how these errors had occurred. A revised version of Fig. 3, now showing the correct data for the ‘Invasion, shNC+/shFXR1#1‑/TGF‑β‑’ (left‑hand) and ‘Invasion, shNC+/shFXR1#2‑/TGF‑β+’ (second on the left) data panels in Fig. 3C, and the ‘Migration, shNC+/shFXR1#1‑/TGF‑β+’, ‘Migration, shNC‑/shFXR1#1+/TGF‑β+’ and ‘Migration, shNC‑/shFXR1#2+/TGF‑β‑’ data panels in Fig. 3D, is shown on the next page. Note that some of the experimental conditions were also labelled incorrectly in the published version of this figure, and these have been corrected in the revised version. The authors regret that the errors occurred in the originally published version of this figure, although these did not grossly affect either the results or the conclusions reported in this article. All the authors agree with the publication of this Corrigendum, and thank the Editor of Oncology Letters for granting them the opportunity to publish this; furthermore. they apologize to the readership for any inconvenience caused. [Oncology Letters 25: 22, 2023; DOI: 10.3892/ol.2022.13608]